Michael Strupp

2.1k total citations
21 papers, 838 citations indexed

About

Michael Strupp is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Michael Strupp has authored 21 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 10 papers in Neurology. Recurrent topics in Michael Strupp's work include Genetic Neurodegenerative Diseases (17 papers), Mitochondrial Function and Pathology (10 papers) and Vestibular and auditory disorders (7 papers). Michael Strupp is often cited by papers focused on Genetic Neurodegenerative Diseases (17 papers), Mitochondrial Function and Pathology (10 papers) and Vestibular and auditory disorders (7 papers). Michael Strupp collaborates with scholars based in Germany, Austria and United States. Michael Strupp's co-authors include Thomas Brandt, R. Kalla, Stefan Glasauer, Andreas Zwergal, Tobias Freilinger, T. Brandt, Martin Dichgans, Katharina Feil, Jens Claaßen and Mario Manto and has published in prestigious journals such as Brain, Neurology and Clinical Neurophysiology.

In The Last Decade

Michael Strupp

19 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Strupp Germany 12 500 427 304 288 157 21 838
Tatiana Brémovà-Ertl Germany 16 145 0.3× 199 0.5× 349 1.1× 142 0.5× 178 1.1× 37 764
Jijun Wan United States 11 463 0.9× 530 1.2× 101 0.3× 145 0.5× 36 0.2× 15 815
Paul Hubbard United Kingdom 7 293 0.6× 152 0.4× 225 0.7× 76 0.3× 52 0.3× 10 637
Carol Charniga United States 15 353 0.7× 484 1.1× 108 0.4× 36 0.1× 52 0.3× 17 798
Julie Napieralski United States 11 212 0.4× 210 0.5× 124 0.4× 143 0.5× 144 0.9× 17 666
Mailis C. McCulloch United Kingdom 13 379 0.8× 385 0.9× 205 0.7× 112 0.4× 69 0.4× 13 881
Yosuke M. Morizawa Japan 9 175 0.3× 167 0.4× 357 1.2× 45 0.2× 25 0.2× 11 660
Pernille Koefoed Denmark 18 297 0.6× 164 0.4× 133 0.4× 105 0.4× 14 0.1× 38 655
S. Kashii Japan 10 155 0.3× 217 0.5× 81 0.3× 70 0.2× 84 0.5× 27 511
Hafsa Mamsa United States 7 137 0.3× 206 0.5× 69 0.2× 52 0.2× 18 0.1× 8 336

Countries citing papers authored by Michael Strupp

Since Specialization
Citations

This map shows the geographic impact of Michael Strupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Strupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Strupp more than expected).

Fields of papers citing papers by Michael Strupp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Strupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Strupp. The network helps show where Michael Strupp may publish in the future.

Co-authorship network of co-authors of Michael Strupp

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Strupp. A scholar is included among the top collaborators of Michael Strupp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Strupp. Michael Strupp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strupp, Michael, et al.. (2025). World-wide survey on the treatment of peripheral vestibular disorders. Frontiers in Neurology. 16. 1540443–1540443.
2.
Hartmann, Annette M., Max Borsche, Andreas Traschütz, et al.. (2025). The Spectrum of Peripheral-Vestibular Deficits and Their Change Over Time in CANVAS/RFC1-Related Ataxia Systematic Review and Meta-Analysis of Quantitative Head-Impulse Testing. The Cerebellum. 24(3). 67–67. 2 indexed citations
3.
Pellerin, David, Carlo Wilke, Matt C. Danzi, et al.. (2024). GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort. EBioMedicine. 102. 105076–105076. 23 indexed citations
4.
Manto, Mario, Jan Cendelín, Michael Strupp, & Hiroshi Mitoma. (2023). Advances in cerebellar disorders: pre-clinical models, therapeutic targets, and challenges. Expert Opinion on Therapeutic Targets. 27(10). 965–987. 2 indexed citations
5.
Becker‐Bense, Sandra, Lena Kaiser, Regina Becker, et al.. (2022). Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?. Journal of Neurology. 270(1). 44–56. 4 indexed citations
6.
Cendelín, Jan, Marija Cvetanović, Mandi Gandelman, et al.. (2021). Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications. The Cerebellum. 21(3). 452–481. 19 indexed citations
7.
Feil, Katharina, Christine Adrion, Sylvia Boesch, et al.. (2021). Safety and Efficacy of Acetyl-DL-Leucine in Certain Types of Cerebellar Ataxia. JAMA Network Open. 4(12). e2135841–e2135841. 18 indexed citations
8.
9.
Muth, Carolin, Julian Teufel, Lüdger Schöls, et al.. (2020). Fampridine and Acetazolamide in EA2 and Related Familial EA. Neurology Clinical Practice. 11(4). e438–e446. 11 indexed citations
10.
Manto, Mario, et al.. (2019). Cerebellar ataxias: an update. Current Opinion in Neurology. 33(1). 150–160. 60 indexed citations
11.
Strupp, Michael, et al.. (2014). The Clinical Spectrum of Autosomal‐Dominant Episodic Ataxias. Movement Disorders Clinical Practice. 1(4). 285–290. 16 indexed citations
12.
Ilg, Winfried, Amy J. Bastian, Sylvia Boesch, et al.. (2013). Consensus Paper: Management of Degenerative Cerebellar Disorders. The Cerebellum. 13(2). 248–268. 125 indexed citations
13.
Kremmyda, Olympia, et al.. (2012). False-Positive Head-Impulse Test in Cerebellar Ataxia. Frontiers in Neurology. 3. 162–162. 38 indexed citations
14.
Strupp, Michael, R. Kalla, Jens Claaßen, et al.. (2011). A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 77(3). 269–275. 122 indexed citations
15.
Kalla, R., Stefan Glasauer, U. Büttner, Thomas Brandt, & Michael Strupp. (2007). 4-Aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain. 130(9). 2441–2451. 78 indexed citations
16.
Strupp, Michael. (2007). Negative treatment trials on Huntington’s disease, ALS and stroke. Journal of Neurology. 254(9). 1309–1311. 1 indexed citations
17.
Strupp, Michael, Andreas Zwergal, & Thomas Brandt. (2007). Episodic Ataxia Type 2. Neurotherapeutics. 4(2). 267–273. 118 indexed citations
18.
Strupp, Michael, R. Kalla, Martin Dichgans, et al.. (2004). Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology. 62(9). 1623–1625. 162 indexed citations
19.
Brandt, Thomas & Michael Strupp. (1997). Episodic Ataxia Type 1 and 2 (Familial Periodic Ataxia/Vertigo). Audiology and Neurotology. 2(6). 373–383. 32 indexed citations
20.
Ballanyi, Klaus, et al.. (1989). Electrophysiological recordings of changes in relative cell volume of neurones, glia, and muscle cells.. PubMed. 582. 25–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatiana Brémovà-Ertl Breakdown of academic impact, for papers by Jijun Wan Breakdown of academic impact, for papers by Paul Hubbard Breakdown of academic impact, for papers by Carol Charniga Breakdown of academic impact, for papers by Julie Napieralski Breakdown of academic impact, for papers by Mailis C. McCulloch Breakdown of academic impact, for papers by Yosuke M. Morizawa Breakdown of academic impact, for papers by Pernille Koefoed Breakdown of academic impact, for papers by S. Kashii Breakdown of academic impact, for papers by Hafsa Mamsa
Rankless by CCL
2026